Parameters | Microarray | Validation cohort (qRT-PCR) | ||
---|---|---|---|---|
CR | IR | CR | IR | |
Number | 9 | 8 | 20 | 19 |
Age (Mean ± SEM) | 49.4 | 48.7 | 51.3 | 50.46 |
FIGO stage | Â | Â | Â | Â |
 I | 1 | 1 | 1 | 1 |
 II |  | 2 | 2 | 1 |
 III | 8 | 4 | 17 | 15 |
 IV |  | 1 | 0 | 2 |
Subtype | ||||
 Low grade serous carcinoma | 1 | 1 | 1 | 3 |
 High grade serous carcinoma | 8 | 5 | 19 | 16 |
 Clear cell carcinoma | 0 | 1 |  |  |
 Endometrioid carcinoma | 0 | 1 |  |  |
Mean serum CA125, m/ml | ||||
 Before platinum | 952.1 | 1872.2 | 1023.1 | 1764.2 |
 After platinum | 17.2 | 343.1 | 14.3 | 294.3 |
 Mortality rate (%) |  |  | 48.1% | 75% |